Antiperspirant OTC Labeling Flexibility Requested By CTFA
This article was originally published in The Rose Sheet
Executive Summary
Antiperspirant labeling should be allowed to drop the "Drug Facts" heading required for OTCs because it "is unnecessary and reduces the space available for important label information," the Cosmetic, Toiletry and Fragrance Association states in an April 11 citizen petition to FDA
You may also be interested in...
Antiperspirant Labeling Determined Appropriate In FDA Petition Denial
Modified labeling is not necessary for OTC antiperspirants because they can readily incorporate the information required under the final monograph in the "Drug Facts" format, FDA says in a letter to the Cosmetic, Toiletry and Fragrance Association
Antiperspirant Labeling Determined Appropriate In FDA Petition Denial
Modified labeling is not necessary for OTC antiperspirants because they can readily incorporate the information required under the final monograph in the "Drug Facts" format, FDA says in a letter to the Cosmetic, Toiletry and Fragrance Association
Cosmetic-Drug Products Subject To FDA's OTC Labeling Final Rule
FDA is not allowing an exemption for cosmetic-drugs in its final rule for standardized OTC drug labeling, announced by Vice President Gore at a March 11 ceremony. The reg is scheduled to be published in the Federal Register March 17.